WaferGen Bio-systems (WGBS) Misses Q1 EPS by 32c, Names New CEO

WaferGen Bio-systems (NASDAQ: WGBS) reported Q1 EPS of ($0.85), $0.32 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $1.15 million versus the consensus estimate of $2.15 million.

WaferGen Bio-systems still sees FY2015 revenue of $8-8.5 million, versus the consensus of $10.65 million.

WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced today that the Company has appointed Rolland D. Carlson, Ph.D., President & CEO, effective immediately. Dr. Carlson assumes this role from Ivan Trifunovich, Ph.D., who has served as President & CEO of WaferGen since March 2012. Dr. Trifunovich has been appointed Executive Chairman of WaferGen.

For earnings history and earnings-related data on WaferGen Bio-systems (WGBS) click here.

You May Also Be Interested In

• Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
• Meta to pay up to $16.68 billion in mass social media settlement
• Pandora (P) Tops Q2 EPS by 12c; offers guidance